Abstract Coronavirus disease 2019 (COVID‐19), can present with a wide spectrum of
severity. Elderly patients with cardiac, pulmonary and metabolic comorbidities are more …

Coronavirus disease 2019 in children presents with milder clinical manifestations than in
adults. On the other hand, the presence of a wide range of inflammatory manifestations …

Abstract The coronavirus disease-2019 (COVID-19) which caused by severe acute
respiratory syndrome-related coronavirus (SARS-CoV-2), is a pandemic threat to global …

In December 2019, a novel coronavirus, now named as SARS-CoV-2, caused a series of
acute atypical respiratory diseases in Wuhan, Hubei Province, China. The disease caused …

Host immune responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
especially in children, are still under investigation. Children with coronavirus disease 2019 …

The difference in morbidity and mortality between adult and pediatric coronavirus disease
2019 infections is dramatic. Understanding pediatric‐specific acute and delayed immune …

Following the spread of the SARS-CoV-2 infection and coronavirus disease 2019 (COVID-
19) to a global pandemic, concerns have arisen for the disease impact in at-risk populations …

The world is facing Coronavirus Disease-2019 (COVID-19) pandemic, which is causing a
large number of deaths and burden on intensive care facilities. It is caused by Severe Acute …

There is a striking age-related disparity in the prevalence and severity of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2)-induced coronavirus disease 2019 …

Background. The profile of cellular immunological responses of children across the
spectrum of COVID-19, ranging from acute SARS-CoV-2 infection to full recovery or Long …